These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8704095)

  • 41. Gene expression of pyrogenic cytokines in Hodgkin's disease lymph nodes.
    Perfetti V; Dragani TA; Paulli M; Castelli G; Bellotti V; Gobbi PG; Merlini G
    Haematologica; 1992; 77(3):221-5. PubMed ID: 1358770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease.
    Xerri L; Birg F; Guigou V; Bouabdallah R; Poizot-Martin I; Hassoun J
    Int J Cancer; 1992 Mar; 50(5):689-93. PubMed ID: 1312061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vimentin expression by Reed-Sternberg cells in Hodgkin's disease.
    Angel CA; Cullen RA; Pringle JH; Lauder I
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):9-11. PubMed ID: 1636252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphological and cytochemical studies of circulating Hodgkin's and Reed-Sternberg cells.
    Malfitano A; Cazzola M; Cavalli P; Gobbi PG; Gorini M; Ascari E; Perugini S
    Basic Appl Histochem; 1980; 24(2):101-7. PubMed ID: 6158308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin's disease.
    Benharroch D; Yermiahu T; Geffen DB; Prinsloo I; Gopas J; Segal S; Aboud M
    Eur J Haematol; 1995 Sep; 55(3):178-83. PubMed ID: 7672090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.
    Kretschmer C; Jones DB; Morrison K; Schlüter C; Feist W; Ulmer AJ; Arnoldi J; Matthes J; Diamantstein T; Flad HD
    Am J Pathol; 1990 Aug; 137(2):341-51. PubMed ID: 2386200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils.
    Jundt F; Anagnostopoulos I; Bommert K; Emmerich F; Müller G; Foss HD; Royer HD; Stein H; Dörken B
    Blood; 1999 Sep; 94(6):2065-71. PubMed ID: 10477736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2.
    Hsu PL; Hsu SM
    Am J Pathol; 1989 Oct; 135(4):735-45. PubMed ID: 2801887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumor necrosis factor alpha.
    Dayer JM
    J Rheumatol Suppl; 1991 Feb; 27():71-5. PubMed ID: 2027136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-3 receptors in Hodgkin's disease.
    Bosshart H
    Am J Pathol; 2003 Jan; 162(1):355-6; author reply 356-7. PubMed ID: 12507919
    [No Abstract]   [Full Text] [Related]  

  • 51. Hodgkin's disease presenting as generalized sclerodermoid skin changes.
    Lewis JE
    Int J Dermatol; 1994 Mar; 33(3):217-8. PubMed ID: 8169029
    [No Abstract]   [Full Text] [Related]  

  • 52. Hodgkin's disease: a cytokine-producing tumor--a review.
    Gruss HJ; Herrmann F; Drexler HG
    Crit Rev Oncog; 1994; 5(5):473-538. PubMed ID: 8519809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth factors in Hodgkin's disease.
    Ford RJ; Mehta S; Davis F; Maizel AL
    Cancer Treat Rep; 1982 Apr; 66(4):633-8. PubMed ID: 6210432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The macrophage hormone interleukin 1 (IL-1) and the tumor necrosis factor. Biological and physiopathological significance].
    Bendtzen K
    Ugeskr Laeger; 1987 Aug; 149(33):2191-6. PubMed ID: 3502435
    [No Abstract]   [Full Text] [Related]  

  • 55. In vivo, interleukin 1 and tumor necrosis factor alpha are essential cytokines involved in the induction of rat alpha 1-acid glycoprotein.
    Chauvelot-Moachon L; Poüs C; Damais C; Levy FE; Raichvarg D; Giroud JP
    Prog Clin Biol Res; 1989; 300():267-70. PubMed ID: 2789390
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum concentrations of cytokines in patients with Hodgkin's disease.
    Blay JY; Farcet JP; Lavaud A; Radoux D; Chouaïb S
    Eur J Cancer; 1994; 30A(3):321-4. PubMed ID: 8204352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interleukin-1, tumor necrosis factor and inflammation].
    Sun GY; Mao BL; Lu BZ
    Sheng Li Ke Xue Jin Zhan; 1993 Jan; 24(1):23-8. PubMed ID: 8332864
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-interleukin-1 reactive cells in Hodgkin's disease.
    Ree HJ; Crowley JP; Dinarello CA
    Cancer; 1987 May; 59(10):1717-20. PubMed ID: 2435398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular basis of targeted chemotherapy: novel concepts with special reference to the treatment of Hodgkin's disease.
    Grunicke HH
    Ann Oncol; 1998; 9 Suppl 5():S125-8. PubMed ID: 9926251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathology induced by inflammatory cytokines. Introduction.
    Ryffel B
    Int Rev Exp Pathol; 1993; 34 Pt B():3-6. PubMed ID: 8458716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.